Currently there are only two home HIV tests: the Home Access HIV-1 Test System and the OraQuick In-home HIV test. If you buy your home test online make sure the HIV test is FDA-approved.
The Home Access HIV-1 Test System is a home collection kit, which involves pricking your finger to collect a blood sample, sending the sample to a licensed laboratory, and then calling in for results as early as the next business day. This test is anonymous. If the test is positive, a follow-up test is performed right away, and the results include the follow-up test. The manufacturer provides confidential counseling and referral to treatment. The tests conducted on the blood sample collected at home find infection later after infection than most lab-based tests using blood from a vein, but earlier than tests conducted with oral fluid.
The OraQuick In-Home HIV Test provides rapid results in the home. The testing procedure involves swabbing your mouth for an oral fluid sample and using a kit to test it. Results are available in 20 minutes. If you test positive, you will need a follow-up test. The manufacturer provides confidential counseling and referral to follow-up testing sites. Because the level of antibody in oral fluid is lower than it is in blood, oral fluid tests find infection later after exposure than do blood tests. Up to 1 in 12 people may test false-negative with this test.
Masciotra S, Luo W, Youngpairoj AeS, Kennedy SM, Wells S, Ambrose K, Sprinkle P, Owen MS. Performance of the Alere DetermineTM HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 serocoverters from the US and HIV-2 infected individuals from Ivory Coast. J Clin Virol. 2013 Dec; 58(suppl.1):e54-e58.
Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM. Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. JClin Virol. 2013 Dec; 58 (Suppl 1): e113-e118.
Find an HIV testing site near you.
Search location, such as: "Atlanta, GA", or "30033".
For more information, please visit gettested.cdc.gov
Please contact GETTESTED-Webmaster@cdc.gov with any comments, suggestions, or concerns.
- HIV Basics
- Who's at Risk for HIV?
- Risk Behavior
- Racial/Ethnic Groups
- HIV Testing
- Prevention Research
- Pre-Exposure Prophylaxis (PrEP)
- Prevention Benefits of HIV Treatment
- Replicating Effective Programs Plus (REP)
- Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention
- Demonstration Projects
- Ongoing Research
- The Serostatus Approach to Fighting the HIV Epidemic
- Policies and Programs
- Affordable Care Act
- DHAP Annual Report
- DHAP Strategic Plan
- Expanded Testing Initiative
- Funding Announcements
- Funding Awards 2012
- Funding Awards 2011
- Funding Awards 2010
- Funding Awards 2009
- Questions and Answers
- Letter of Intent
- Workshops and Web Conferences
- Eligibility Criteria and Maps of MSAs and MDs
- After You Apply
- New Awards for 12-1201
- FY 2012 Funding for Category C
- Grantee Orientation Materials
- Comprehensive Program Plan
- HIV Planning Guidance
- Capacity Building Assistance for Health Departments
- Related Links
- High Impact Prevention
- HIV-Related Laws
- Progress Reports
- Program Planning
- Guidelines and Recommendations
- Training and Conferences
- Statistics Center
- Statistics Overview
- Surveillance Overview
- Surveillance Systems
- Surveillance Reports and Slide Sets
- Recommendations and Guidelines
- Other Resources
- Resource Library